HIF1A and neoplasm: C/EBPδ inhibits FBXW7 in ER + cells, releasing HIF-1α and IL-6Rα expression and activating downstream STAT3 phosphorylation, promoting in vitro calmodulin transformation, sphere formation, and patient-derived xenograft (PDX) tumor metastasis [24].